Replimune (REPL) Depreciation & Amortization (CF) (2017 - 2025)

Replimune's (REPL) quarterly Depreciation & Amortization (CF) came in at $800000.0 in Q4 2025, down 20.0% year-on-year from $1.0 million in Q4 2024, and little changed quarter-over-quarter from $800000.0 in Q3 2025.

Replimune (REPL) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends

Replimune has disclosed Depreciation & Amortization (CF) across 9 years of filings, most recently posting $800000.0 for Q4 2025.

  • Depreciation & Amortization (CF) for Q4 2025 came in at $800000.0, down 20.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.3 million (down 0.91% YoY), and the FY2025 annual result was $3.5 million, up 31.9% from the prior year.
  • Depreciation & Amortization (CF) came in at $800000.0 for Q4 2025 at Replimune, roughly flat from $800000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.0 million in Q4 2024 to a low of $481000.0 in Q1 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $691000.0 (2022), against an average of $681550.0.
  • Across the five-year window, Depreciation & Amortization (CF) jumped 56.31% in 2021 and decreased 20.0% in 2025, its largest moves.
  • Replimune's Depreciation & Amortization (CF) stood at $548000.0 in 2021, then gained by 24.45% to $682000.0 in 2022, then gained by 2.64% to $700000.0 in 2023, then surged by 42.86% to $1.0 million in 2024, then retreated by 20.0% to $800000.0 in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $800000.0 (Q4 2025), $800000.0 (Q3 2025), and $873000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - 1,395.22
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -1,330.00
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 55.90 Mn
9 Abivax 91.71 Bn 91.71 Bn - 429,663.65
10 Replimune 780.01 Mn 510.88 Mn - 800,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 800,000.00
Dec 31, 2025 800,000.00
Sep 30, 2025 800,000.00
Sep 30, 2025 800,000.00
Jun 30, 2025 873,000.00
Jun 30, 2025 873,000.00
Mar 31, 2025 802,000.00
Mar 31, 2025 802,000.00
Dec 31, 2024 1.00 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 900,000.00
Sep 30, 2024 900,000.00
Jun 30, 2024 700,000.00
Jun 30, 2024 700,000.00
Mar 31, 2024 705,000.00
Mar 31, 2024 705,000.00
Dec 31, 2023 700,000.00
Dec 31, 2023 700,000.00
Sep 30, 2023 700,000.00
Sep 30, 2023 700,000.00